Diagnosis and management of primary aldosteronism: An updated review
- 30 April 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Annals of Medicine
- Vol. 45 (4), 375-383
- https://doi.org/10.3109/07853890.2013.785234
Abstract
Primary aldosteronism (PA) is the most common secondary form of arterial hypertension, with a particularly high prevalence among patients with resistant hypertension. Aldosterone has been found to be associated with cardiovascular toxicity. Prolonged aldosteronism leads to higher incidence of cardiac events, glomerular hyperfiltration, and potentially bone/metabolic sequels. The wider application of aldosterone/renin ratio as screening test has substantially contributed to increasing diagnosis of PA. Diagnosis of PA consists of two phases: screening and confirmatory testing. Adrenal imaging is often inaccurate for differentiation between an adenoma and hyperplasia, and adrenal venous sampling is essential for selecting the appropriate treatment modality. The etiologies of PA have two main subtypes: unilateral (aldosterone-producing adenoma) and bilateral (micro- or macronodular hyperplasia). Aldosterone-producing adenoma is typically managed with unilateral adrenalectomy, while bilateral adrenal hyperplasia is amenable to pharmacological approaches using mineralocorticoid antagonists. Short-term treatment outcome following surgery is determined by factors such as preoperative blood pressure level and hypertension duration, but evidence regarding long-term treatment outcome is still lacking. However, directed treatments comprising of unilateral adrenalectomy or mineralocorticoid antagonists still potentially reduce the toxicities of aldosterone. Utilizing a physician-centered approach, we intend to provide up-dated information on the etiology, diagnosis, and the management of PA.This publication has 71 references indexed in Scilit:
- KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial HyperaldosteronismHypertension, 2012
- Prevalence of Primary Aldosteronism in Patient's Cohorts and in Population-based Studies - A Review of the Current LiteratureHormone and Metabolic Research, 2011
- Primary Aldosteronism and Metabolic SyndromeHormone and Metabolic Research, 2011
- K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary HypertensionScience, 2011
- Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronismOrphanet Journal of Rare Diseases, 2010
- Intrarenal Hemodynamics in Primary Aldosteronism before and after TreatmentJournal of Clinical Endocrinology & Metabolism, 2009
- Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronismJournal of Hypertension, 2008
- A Novel Form of Human Mendelian Hypertension Featuring Nonglucocorticoid-Remediable AldosteronismJournal of Clinical Endocrinology & Metabolism, 2008
- Captopril Test Can Give Misleading Results in Patients With Suspect Primary AldosteronismHypertension, 2007
- Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.Hypertension, 1983